Elma S. Hawkins

ELMA S. HAWKINS, PhD, MBA, was named as CEO of Advanced Viral Research
Corp. on February 12, 2004. Dr. Hawkins also serves as a member of the
Executive Management Committee for ADVR. Previously, Dr. Hawkins served
as Vice Chairman of Antigenics, a biotechnology company which is
developing personalized immunotherapeutics and revolutionary treatments
for cancers, autoimmune diseases and infections. She has also had prior
experience in corporate development and regulatory affairs at Genzyme
Corporation and held preclinical and regulatory positions at Warner-
Lambert/Parke Davis Pharmaceuticals. Dr. Hawkins brings with her two
decades of drug development and management experience which should serve
Advanced Viral Research Corp. well in advancing its lead product,
AVR118, through clinical trials and toward commercialization.